CERO Insider Trading

Insider Ownership Percentage: 18.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $907,649.00

CERo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CERo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CERo Therapeutics Share Price & Price History

Current Price: $2.06
Price Change: Price Increase of +0.26 (14.44%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for CERO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CERo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2024Bioventures Opportunities G YkMajor ShareholderSell29,989$6.00$179,934.00130,051View SEC Filing Icon  
12/11/2024Bioventures Opportunities G YkMajor ShareholderSell13,438$8.00$107,504.00176,186View SEC Filing Icon  
12/9/2024Bioventures Opportunities G YkMajor ShareholderSell8,505$11.00$93,555.00205,333View SEC Filing Icon  
12/6/2024Bioventures Opportunities G YkMajor ShareholderSell12,368$12.00$148,416.00213,839View SEC Filing Icon  
10/10/2024Bioventures Opportunities G YkMajor ShareholderSell32,500$10.00$325,000.00226,207View SEC Filing Icon  
9/25/2024Stuart M SloanMajor ShareholderSell5,324$10.00$53,240.00210,679View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CERo Therapeutics (NASDAQ:CERO)

29.64% of CERo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CERo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/7/2025Avantax Planning Partners Inc.2,585,151$0.16M0.0%+89.9%171.999%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CERo Therapeutics logo
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Read More on CERo Therapeutics

Today's Range

Now: $2.06
Low: $1.80
High: $2.06

50 Day Range

MA: $4.05
Low: $1.80
High: $11.00

52 Week Range

Now: $2.06
Low: $1.70
High: $1,238.00

Volume

318,897 shs

Average Volume

779,227 shs

Market Capitalization

$3.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of CERo Therapeutics?

CERo Therapeutics' top insider investors include:
  1. Bioventures Opportunities G Yk (Major Shareholder)
  2. Stuart M Sloan (Major Shareholder)
Learn More about top insider investors at CERo Therapeutics.

Who are the major institutional investors of CERo Therapeutics?

CERo Therapeutics' top institutional investors include:
  1. Avantax Planning Partners Inc. — 172.00%
Learn More about top institutional investors of CERo Therapeutics stock.

Which institutional investors are buying CERo Therapeutics stock?

Within the previous quarter, CERO stock was bought by institutional investors including:
  1. Avantax Planning Partners Inc.